Advertisement
Screener

GeneDx Holdings Corp. (WGS) Long-Term Debt, Maturity, after Year Five

2.8 / 5 stars · 68/120 Roast Me

GeneDx Holdings Corp. Long-Term Debt, Maturity, after Year Five

GeneDx Holdings Corp. (WGS) had Long-Term Debt, Maturity, after Year Five of $762.00 thousand as of 2023-12-31, per its 10-K filed 2024-02-23.

Discontinued › Notes › Commitment and Contingencies

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2024-02-23

  • 2023-12-31: Long-Term Debt, Maturity, after Year Five $762.00K.
  • 2022-12-31: Long-Term Debt, Maturity, after Year Five $2.05M.
  • 2021-12-31: Long-Term Debt, Maturity, after Year Five $3.60M.
Period endLong-Term Debt, Maturity, after Year Five
2023-12-31$762.00K
10-K · filed 2024-02-23
2022-12-31$2.05M
10-K · filed 2023-03-16
2021-12-31$3.60M
10-K · filed 2022-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
Pennant Group, Inc. (PNTG)United States$1.386B39.84
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B